安徽华人健康医药股份有限公司 第一章 总则 第二章 信息披露暂缓与豁免的适用情形 第一条 为规范安徽华人健康医药股份有限公司（以下简称"公司"）信息披 露暂缓与豁免行为，确保公司依法合规履行信息披露义务，保护投资 者的合法权益，根据《中华人民共和国证券法》（以下简称"《证券 法》"）、《上市公司信息披露暂缓与豁免管理规定》《深圳证券交 易所创业板股票上市规则》（以下简称"《上市规则》"）等相关法 律法规，并结合《公司章程》及公司《信息披露管理制度》等有关规 定，制定本制度。 第二条 公司和其他信息披露义务人暂缓、豁免披露临时报告，在定期报告、 临时报告中豁免披露按照中国证券监督管理委员会（以下简称"中国 证监会"）及深圳证券交易所（以下简称"深交所"）规定或者要求披 露的内容，适用本制度。 第三条 公司应当审慎确定信息披露暂缓、豁免事项，并采取有效措施防止暂 缓或者豁免披露的信息泄露。 第四条 公司和其他信息披露义务人应当真实、准确、完整、及时、公平地披 露信息，不得滥用暂缓或者豁免披露规避信息披露义务、误导投资者， 不得实施内幕交易、操纵市场等违法行为。 第十四条 公司和其他信息披露义务人应当在年度报告、半 ...

奥特佳新能源科技股份有限公司信息披露暂缓与豁免业务管理制度 奥特佳新能源科技股份有限公司 信息披露暂缓与豁免业务管理制度 （本制度经公司第六届董事会第三十三次会议审议通过，自 2025 年 7 月 2 日起执行） 《深圳证券交易所股 票上市规则》 （以下简称"《股票上市规则》"）、 第一章 总则 第一条 为规范奥特佳新能源科技股份有限公司（以下简称"公司"） 信息披露暂缓与豁免业务的管理，确保公司信息披露的合规性、及时性 和公平性，保护投资者合法权益，根据《中华人民共和国公司法》 （以下 简称"《公司法》"）、 《上市公司信息披露管理办法》 《上市公司信息披露暂缓 与豁免管理规定》等法律、法规以及公司章程的相关规定，制定本制度。 第二条 公司和其他信息披露义务人暂缓、豁免披露临时报告，在定 期报告、临时报告中豁免披露中国证券监督管理委员会（以下简称"证 监会"）和深圳证券交易所（以下简称"深交所" ）规定或者要求披露的 内容，适用本制度。 第三条 公司应自行审慎判断应当披露的信息是否存在《股票上市规 则》及深交所其他相关业务规则中规定的可暂缓、豁免信息披露的情形， 履行内部审核程序后实施，并接受深交所对有关信 ...

广州金逸影视传媒股份有限公司 Guangzhou Jinyi Media Corporation 广州金逸影视传媒股份有限公司 信息披露暂缓与豁免制度 《中华人民共和国公司法》 （以下简称" 《公司法》" ）《上市公司信息披露管 (三) 披露后可能严重损害公司、他人利益的其他情形。 商业秘密的，可以采用代称、汇总概括或者隐去关键信息等方式豁免披露 该部分信息；在采用上述方式处理后披露仍存在泄密风险的，可以豁免披 露临时报告。 第一章 总则 第一条 广州金逸影视传媒股份有限公司（以下简称"公司"）为规范信息披露暂缓 与豁免行为，确保公司及相关信息披露义务人（ 以下简称（ 信息披露义 务人"）依法依规履行信息披露义务，保护投资者的合法权益，公司根据 第二条 公司及信息披露义务人按照《上市规则》及证券交易所其他业务规则等相 关法律法规、规范性文件的规定，办理信息披露暂缓、豁免事务的，适用 本制度。 第三条 公司及信息披露义务人应自行审慎判断应当披露的信息是否存在《上市规 则》及证券交易所其他相关业务规则中规定的暂缓、豁免情形，并接受证 券交易所对信息披露暂缓、豁免事项的事后监管。 第四条 公司和其他信息披露义务人有 ...

Core Points - The article outlines the information disclosure policy of Zhejiang Aokang Footwear Co., Ltd, focusing on the conditions under which the company can postpone or exempt disclosures to protect its interests and those of investors [1][2][5] - The policy is established in accordance with the Securities Law of the People's Republic of China and the Shanghai Stock Exchange Listing Rules, ensuring compliance with legal and regulatory requirements [1][5] Group 1 - The company can postpone disclosure if the information is uncertain, classified as a temporary business secret, or if timely disclosure may harm the company's interests or mislead investors, provided that insiders have signed confidentiality agreements [1][2] - The company can exempt disclosure if the information is classified as a state secret or business secret, and disclosing it would violate confidentiality laws or harm the interests of the company and investors [2][5] - The definition of "business secret" includes information that is not publicly known, provides economic benefits, and is protected by confidentiality measures, while "state secret" refers to information related to national security that is restricted to a limited audience [2][5] Group 2 - The company must ensure that postponed disclosures meet specific conditions, including the absence of information leaks, written confidentiality commitments from insiders, and no abnormal trading activity in the company's stock [3][4] - If the reasons for postponement or exemption are no longer valid or the time limit has expired, the company must promptly disclose the relevant information and the circumstances surrounding the postponement or exemption [4][5] - The company has established a responsibility accountability mechanism for information disclosure, ensuring that any failure to comply with the policy will result in appropriate disciplinary actions against responsible personnel [4][5]

Core Points - The company has established a system for the deferral and exemption of information disclosure to ensure compliance with relevant laws and regulations [1][2][3] - The system outlines conditions under which information can be deferred or exempted from disclosure, particularly concerning state secrets and commercial secrets [2][3][5] - The company must maintain confidentiality and prevent the leakage of sensitive information through various means [3][4][5] Summary by Sections Information Disclosure Management - The system is designed to regulate the deferral and exemption of information disclosure in accordance with the Securities Law and the Shanghai Stock Exchange rules [1] - Information disclosure obligations must be fulfilled by the company and related parties as per the established regulations [1][2] Conditions for Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or commercial secrets that could lead to unfair competition or harm to the company's interests [2][3] - The definition of commercial secrets includes information that is not publicly known, provides economic benefits, and is subject to confidentiality measures [2][3] Procedures and Responsibilities - The company must document any deferral or exemption decisions, including the reasons and the individuals privy to the information [4][5] - Any deferred or exempted information must be disclosed promptly if the reasons for deferral are no longer valid or if the information becomes public [3][5] Compliance and Accountability - The company is responsible for ensuring that any deferral or exemption complies with the relevant rules and must take corrective actions if there are violations [5][6] - The board of directors is tasked with interpreting and revising the system, which will take effect upon approval [6]

Core Viewpoint - The document outlines the management system for the deferral and exemption of information disclosure by China Film Industry Group Co., Ltd, ensuring compliance with relevant regulations and protecting sensitive information [1][2][3]. Group 1: General Principles - The company aims to standardize the deferral and exemption of information disclosure to comply with laws and regulations [1]. - Information disclosure must be truthful, accurate, complete, timely, and fair, avoiding misuse of deferral or exemption to mislead investors [1][2]. Group 2: Applicable Situations for Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or could violate confidentiality regulations [1][2]. - Business secrets can be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [2][3]. Group 3: Approval and Registration Procedures - The board of directors oversees the deferral and exemption process, with the board secretary responsible for coordination [3][4]. - Specific internal approval procedures must be followed for deferring or exempting information disclosure [4][5]. Group 4: Subsequent Management of Deferred and Exempted Information - The company must report deferred or exempted information to regulatory bodies within ten days after the announcement of periodic reports [5][6]. - If the reasons for deferral or exemption are eliminated, or if information leaks occur, the company must disclose the information promptly [6]. Group 5: Accountability - Violations of the established procedures may lead to accountability measures against responsible personnel [6][7].

Core Viewpoint - The document outlines the regulations and procedures for Jiangxi Fuxiang Pharmaceutical Co., Ltd. regarding the deferral and exemption of information disclosure, emphasizing the importance of protecting state secrets and commercial confidentiality [2][3][4]. Group 1: General Principles - The company aims to standardize the deferral and exemption of information disclosure to enhance regulatory oversight and protect investors' rights [2]. - The company will adhere to relevant laws and regulations, including the Shenzhen Stock Exchange's rules, when handling information disclosure deferrals and exemptions [2][3]. Group 2: Scope of Deferral and Exemption - Information that involves state secrets or could violate confidentiality regulations may be exempted from disclosure if sufficient evidence is provided [3][4]. - Commercial secrets can be deferred or exempted from disclosure if they meet specific criteria, such as potential harm to the company or others if disclosed [3][4]. Group 3: Internal Management Procedures - The company must carefully determine the scope of deferral and exemption, ensuring that it does not misuse these provisions [5]. - The board of directors will oversee the management of deferral and exemption matters, with the board secretary responsible for coordination [5][6]. Group 4: Documentation and Reporting - The company must maintain records of any deferred or exempted disclosures, including the type of information and the internal review process [6][7]. - If the reasons for deferral or exemption are no longer valid, the company must promptly disclose the information [6][7].

General Principles - The company establishes a system for the deferral and exemption of information disclosure to ensure compliance with legal obligations under the Securities Law and relevant regulations [2][3] - The system applies to both the company and other information disclosure obligors, allowing for deferral or exemption of disclosures required by the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3] Applicable Situations for Deferral and Exemption - The company must carefully determine the circumstances under which information disclosure can be deferred or exempted, following internal review procedures [3][4] - Deferral or exemption is permitted if the information involves state secrets or other matters that could violate confidentiality regulations [3][4] - Information related to commercial secrets can also be deferred or exempted if it meets specific criteria, such as potential harm to the company or others if disclosed [3][4] Internal Management Process for Deferral and Exemption - The company’s board secretary is responsible for organizing and coordinating deferral and exemption matters under the board's leadership [5][6] - A detailed registration process is required for any deferral or exemption, including the type of information and the reasons for deferral [5][6] - The company must maintain records of deferral and exemption decisions for a period of ten years [5][6] Accountability and Compliance - The company has established a mechanism for accountability regarding deferral and exemption practices, holding responsible parties accountable for non-compliance [6][7] - Any deferral or exemption must be disclosed promptly once the reasons for deferral are no longer applicable [4][6]

Core Viewpoint - The document outlines the information disclosure deferral and exemption management system for Anhui Rongzhi Rixin Technology Co., Ltd, aiming to ensure compliance with relevant laws and regulations while protecting the company's interests and sensitive information [1][2]. Group 1: General Provisions - The system is established to regulate the deferral and exemption of information disclosure by the company and its related parties, ensuring compliance with the Securities Law of the People's Republic of China and other relevant regulations [1][2]. - "Information disclosure obligors" include the company, its directors, general manager, financial officer, board secretary, and other senior management, as well as major responsible persons from departments and subsidiaries [1][2]. Group 2: Scope of Deferral and Exemption - Information disclosure can be deferred if it involves uncertainty or temporary business secrets that may harm the company's interests or mislead investors [2][3]. - Exemption from disclosure is allowed for information that is classified as state secrets, business secrets, or sensitive commercial information, where disclosure could violate confidentiality laws or harm the company and investors [2][3]. Group 3: Procedures for Deferral and Exemption - Information disclosure obligors must carefully determine the matters for deferral or exemption and take effective measures to prevent leaks of such information [4][5]. - The securities department is responsible for organizing and coordinating the specific affairs related to information disclosure deferral and exemption [4]. Group 4: Responsibilities and Obligations - Individuals with knowledge of deferred or exempted information must ensure that the number of people aware of such information is minimized and must not disclose it [5][6]. - If deferred or exempted information is leaked or if the reasons for deferral or exemption are no longer valid, the company must promptly verify the situation and disclose the information [6][7]. Group 5: Reporting and Documentation - The company must submit relevant registration materials regarding deferred or exempted disclosures to the local securities regulatory authority and stock exchange within ten days after the announcement of periodic reports [7]. - The system includes specific documentation requirements for deferral and exemption matters, including reasons, types of documents involved, and internal approval processes [4][5].

上海复星医药（集团）股份有限公司 信息披露暂缓与豁免业务管理制度 （2025年修订） 第一条 为规范上海复星医药（集团）股份有限公司（以下简称"本公司"或 "上市公司"）信息披露暂缓与豁免行为，依法合规履行信息披露义务，保护投 资者的合法权益，根据《中华人民共和国证券法》、中国证券监督管理委员会《上 市公司信息披露暂缓与豁免管理规定》 《上海证券交易所股票上市规则》 第三条 本公司和其他信息披露义务人应当审慎确定信息披露暂缓、豁免事 项，并履行内部审核程序后方可实施。 第四条 本公司和其他信息披露义务人有确实充分的证据证明拟披露的信息 涉及国家秘密或者其他因披露可能导致违反国家保密规定、管理要求的事项（以 下统称"国家秘密"），依法豁免披露。 （以下简 称"《股票上市规则》"）、《香港联合交易所有限公司证券上市规则》（以下简称 "《香港上市规则》"）、香港《证券及期货条例》、香港证券及期货事务监察委员 会《内幕消息披露指引》 《上海复星医药（集团）股份有限公司章程》 （以下简称 "《公司章程》"）、 《上海复星医药（集团）股份有限公司信息披露制度》 （以下简 称"《信息披露制度》"）等规定，特制定本制度。 第 ...